Cancer is one of the world's most urgent unmet medical needs. ODS Pharma’s high-quality oncology drugs improve the lives of people with cancer.
Leading Products for Cancer Treatments
ODS offers a range of leading products for the treatment of cancer.We are reinforcing our global marketing activities, aiming to provide high-quality medicines to patients worldwide to fight cancer. We constantly strive to make high quality oncology products that offer treatment to cancer patients and improve the overall quality of life by reducing healthcare costs.
Except Pain, Cancer Has Costs Too
Keeping that in mind that Patients are at risk for not adhering to their treatments due to cost, we address ways to bring down costs of pharmaceuticals services while providing the highest level of safe, innovative, compassionate care for patients with cancer and to Improve the quality of the life of people Iiving with cancer, and restore their hope for eradication of cancer.
Paclitaxel is an anti -cancer chemotherapy drug classified as a “plant alkaloid”, a “taxane” and an “antimicrotubule agent”. Paclitaxel’s mechanism of action involves interfering with the normal breakdown of microtubules during cell division.
PACLITAXEL injections are used to treat advanced cancers, including:
- Ovarian cancer
- Breast cancer
- Non-small cell lung cancer
- Bladder cancer
- Prostate cancer
- Kaposi sarcoma.
30, 100, 150, 300 mg
Vinorelbine ODS is an anti-mitotic chemotherapy drug that is given as a treatment for some types of cancer, including breast cancer and non-small cell Lung cancer. The antitumor activity of Vinorelbine ODS is due to its inhibition of mitosis through interaction with microtubules. One of the roles of microtubules is to aid in the replication of cells. By disrupting this function, Vinorelbine inhibits cell replication, including the replication of cancer cells. Vinorelbine is the first SNOR semi-synthetic vinca alkaloid. It is obtained through semi-synthesis of alkaloids extracted from the rosy periwinkle, Catharanthus roseus.
Epirubicin ODS is a cancer medication that interferes with the growth and spread of cancer cells in the body. Epirubicin ODS is an anthracycline topoisomerase II inhibitor that has been indicated as a component of adjuvant therapy in patients with evidence of axillary node tumors following the resection of primary breast cancer. Similar to other anthracyclines, Epirubicin ODS acts by intercalating DNA strands. Intercalation results in a complex formation that inhibits DNA and RNA synthesis. It also triggers DNA cleavage by topoisomerase II, resulting in mechanisms that lead to cell death (apoptosis).
10, 20, 50, 150, 200 mg
Docetaxel ODS is a clinically well-established anti -mitotic chemotherapy medication that works by interfering with cell division. This medication is classified as a “plant alkaloid”, a “taxane” and an “antimicrotubule agent”.
The taxoid Docetaxel ODS is a cornerstone of treatment for several types of cancer and is available at an affordable price in many countries. Docetaxel is a high-quality treatment approved by the FDA for the treatment of:
- Breast Cancer
- Non-Small Cell Lung Cancer
- Prostate Cancer
- Gastric Adenocarcinoma
20, 80, 140, 160 mg
Doxorubicin is a type of chemotherapy drug called an anthracycline. It slows or stops the growth of cancer cells. One way that doxorubicin works is by blocking an enzyme called topo isomerase 2 that cancer cells need in order to divide and grow.
Indications and Usage for Doxorubicin:
Doxorubicin is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy.
AIDS-Related Kaposi’s sarcoma
Doxorubicin is indicated for the treatment of AIDS-related Kaposi’s sarcoma in patients after failure of prior systemic chemotherapy or intolerance to such therapy.
Doxorubicin, in combination with bortezomib, is indicated for the treatment of patients with multiple myeloma who have not previously received bortezomib and have received at least one prior therapy.
Our Products Are Manufactured & Registered in GERMANY & According to the HIGHEST QUALITY STANDARDS
We focus on providing medications that are a genuine advance on the current standards of healthcare.
Converting scientific innovation into hope and solutions for patients.
Wise scientific and commercial expertise.
Products with EMEA regulatory standards compliance.
Implementing the PhV systems to monitor the safety of drugs.
Dedication to working with healthcare professionals and our business partners to establish positive working collaboration.
RESEARCH AND DEVELOPMENT
With the goal of improving the lives of people affected by cancer, oncology research at ODS is committed to discovering, developing and delivering innovative medicines for the treatment of cancer.
We invested extensively in a Research & Development program to create different R&D services, as ODS aims to offer affordable and efficient cancer therapies through the discovery and development of innovative therapeutics that target specific molecular pathways associated with cancer.
R&D at ODS focuses on the validation of innovative product development, product and manufacturing monitoring, as well as the supervision of various levels of drug development, from pre-clinical studies, managing clinical trials, and processes all the way up to commercialization.
The Company is currently developing a range of pharmaceutical product projects based on its approach to provide leading products for the oncology indications.